3/13/2013 – F.D.A. Plans Looser Rules on Approving Alzheimer’s DrugsThe Food and Drug Administration plans to loosen the rules for approving new treatments for Alzheimer’s disease. Read the full article at The New York Times. https://longevity.stanford.edu/wp-content/uploads/2025/05/SCL-Logo-1-300x118.png 0 0 admin https://longevity.stanford.edu/wp-content/uploads/2025/05/SCL-Logo-1-300x118.png admin2013-03-13 19:59:062013-03-13 19:59:063/13/2013 – F.D.A. Plans Looser Rules on Approving Alzheimer’s Drugs
